Speech Title: Transforming Diagnostics and Treatment Through Computational Pathology: A Deep Learning Approach for Precise Biomarker Quantification and Patient Selection
Biography: Dr. Hadassah Sade leads AstraZeneca's Computational Pathology division, an innovative team utilizing artificial intelligence, digital pathology, and translational data science to accelerate medicine development and delivery. Her division focuses on leveraging AI-based computational pathology solutions to enhance patient selection for clinical trials and treatment regimens. Under Dr. Sade's leadership, the team transforms drug development landscapes, advancing life-changing therapies for patients in need. Her vision and expertise position AstraZeneca as a leader in integrating technology and science in healthcare, ultimately benefiting patients and the broader medical community through timely, effective treatments.
